Gastrointestinal Endoscopy
Volume 71, Issue 3 , Pages 500-504, March 2010

Impact of EUS-guided FNA on management of gastric carcinomaDisclosure

  • Hazem Hassan, MD
    • ,
  • Peter Vilmann, MD, DSc

      Affiliations

    • Corresponding Author InformationReprint requests: Peter Vilmann MD, DSc, Department of Surgical Gastroenterology, Gentofte Hospital, Copenhagen University, Niels Andersensvej 65, DK-2900 Hellerup, Denmark.
    • ,
  • Vijay Sharma, MD

Received 14 July 2009; accepted 20 October 2009.

Background

EUS is an integral part of the pretherapeutic evaluation program for patients with upper GI cancer.

Objective

To evaluate the impact of EUS-guided FNA on the clinical management of patients with gastric cancer.

Design

The study included patients with confirmed gastric carcinoma who were referred to the Department of Surgical Gastroenterology, Gentofte Hospital, Copenhagen University, Copenhagen, Denmark, during a 6-year period (2001-2007).

Setting

The patients underwent standard pretherapeutic evaluation. If no signs of incurability were detected, the patients were offered EUS and EUS-guided FNA. EUS-guided FNA was performed when lymph nodes or lesions were considered to be distant metastases. A board of surgeons was asked to evaluate the management of the patients after the results obtained by EUS-guided FNA were revealed.

Patients

This study involved 234 patients with gastric carcinoma.

Intervention

EUS-guided FNA.

Main Outcome Measurements

Number of patients with distant metastasis diagnosed by EUS-guided FNA, with the avoidance of unnecessary surgery.

Results

A total of 81 consecutive patients underwent EUS-guided FNA. Ninety-nine lesions were targeted, and 61 (62%) of these lesions were found to be malignant. In 38 of 81 patients (42%) distant metastases were confirmed by EUS-guided FNA. As judged by the board of surgeons, EUS-guided FNA changed the management plan in 34 of 234 patients (15%).

Limitation

The positive EUS-guided FNA diagnoses were not surgically verified.

Conclusion

EUS-guided FNA is a very important modality and should be integrated as a routine procedure in the preoperative staging algorithm of gastric cancer.

Abbreviations: TNM, tumor, nodes, metastasis cancer staging method, UICC, International Union Against Cancer

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

Disclosure All authors disclosed no financial relationships relevant to this publication.

 See CME section; p. 596

 Current affiliations: Department of Surgical Gastroenterology (H.H., P.V.), Gentofte Hospital, Copenhagen University, Hellerup, Denmark, Gastroenterology Department (V.S.), Mahatma Gandhi Medical College, Jaipur, India.

PII: S0016-5107(09)02698-4

doi:10.1016/j.gie.2009.10.044

Gastrointestinal Endoscopy
Volume 71, Issue 3 , Pages 500-504, March 2010

Article Tools